- Home
- MANH vs TOI Comparison
MANH vs TOI Comparison
Compare MANH & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MANH
- TOI
- Stock Information
- Founded
- MANH 1990
- TOI 2007
- Country
- MANH United States
- TOI United States
- Employees
- MANH N/A
- TOI N/A
- Industry
- MANH Computer Software: Prepackaged Software
- TOI Medical/Nursing Services
- Sector
- MANH Technology
- TOI Health Care
- Exchange
- MANH Nasdaq
- TOI Nasdaq
- Market Cap
- MANH N/A
- TOI 266.8M
- IPO Year
- MANH 1998
- TOI N/A
- Fundamental
- Price
- MANH $188.78
- TOI $3.19
- Analyst Decision
- MANH Buy
- TOI
- Analyst Count
- MANH 8
- TOI 0
- Target Price
- MANH $210.14
- TOI N/A
- AVG Volume (30 Days)
- MANH 894.4K
- TOI 1.7M
- Earning Date
- MANH 07-22-2025
- TOI 05-14-2025
- Dividend Yield
- MANH N/A
- TOI N/A
- EPS Growth
- MANH 14.38
- TOI N/A
- EPS
- MANH 3.50
- TOI N/A
- Revenue
- MANH $1,050,587,000.00
- TOI $403,152,000.00
- Revenue This Year
- MANH $3.71
- TOI $23.95
- Revenue Next Year
- MANH $6.57
- TOI N/A
- P/E Ratio
- MANH $53.93
- TOI N/A
- Revenue Growth
- MANH 9.18
- TOI 17.64
- 52 Week Low
- MANH $140.81
- TOI $0.13
- 52 Week High
- MANH $312.60
- TOI $3.50
- Technical
- Relative Strength Index (RSI)
- MANH 55.63
- TOI 61.85
- Support Level
- MANH $181.86
- TOI $2.82
- Resistance Level
- MANH $192.74
- TOI $3.35
- Average True Range (ATR)
- MANH 3.66
- TOI 0.37
- MACD
- MANH -0.93
- TOI -0.00
- Stochastic Oscillator
- MANH 44.76
- TOI 85.32
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.